XML 63 R44.htm IDEA: XBRL DOCUMENT v3.25.4
Nature of Business and Basis of Presentation (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Sep. 30, 2025
subsidiary
Jun. 30, 2026
£ / shares
Jun. 30, 2026
USD ($)
$ / shares
shares
Dec. 31, 2025
£ / shares
Dec. 31, 2025
USD ($)
Sep. 29, 2025
Dec. 31, 2024
£ / shares
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Share Repurchase Program [Line Items]                  
Number of new subsidiaries | subsidiary 2                
Ordinary shares, nominal value (per share) | £ / shares       £ 0.000025     £ 0.000025    
Merger agreement extension period           60 days      
Cash and cash equivalents | $         $ 71,852     $ 112,400 $ 142,090
Accumulated deficit | $         $ 304,092     $ 237,664  
Forecast                  
Share Repurchase Program [Line Items]                  
Ordinary shares, nominal value (per share) | £ / shares   £ 0.000025              
Number of depositary shares per share of common stock (in shares) | shares     1            
Forecast | Becaon Topco, Inc                  
Share Repurchase Program [Line Items]                  
Ordinary shares, nominal value (per share) | $ / shares     $ 0.0001            
Self-tender offer authorized amount to purchase | $     $ 27,000            
Forecast | Clywedog Therapeutics, Inc.                  
Share Repurchase Program [Line Items]                  
Ordinary shares, nominal value (per share) | $ / shares     $ 0.0001            
Preferred stock par value (in dollars per share) | $ / shares     $ 0.0001            
Forecast | Scheme Shares                  
Share Repurchase Program [Line Items]                  
Stock conversion ratio     1            
Forecast | Clywedog Capital Stock                  
Share Repurchase Program [Line Items]                  
Stock conversion ratio     4.358932